Document Detail


Gel point and fractal microstructure of incipient blood clots are significant new markers of hemostasis for healthy and anticoagulated blood.
MedLine Citation:
PMID:  20566899     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Here we report the first application of a fractal analysis of the viscoelastic properties of incipient blood clots. We sought to ascertain whether the incipient clot's fractal dimension, D(f,) could be used as a functional biomarker of hemostasis. The incipient clot is formed at the gel point (GP) of coagulating blood, the GP demarcating a functional change from viscoelastic liquid to a viscoelastic solid. Incipient clots formed in whole healthy blood show a clearly defined value of D(f) within a narrow range that represents an index of clotting in health, where D(f) = 1.74 (± 0.07). A significant relationship is found between the incipient clot formation time, T(GP), and the activated partial thromboplastin time, whereas the association of D(f) with the microstructural characteristics of the incipient clot is supported by its significant correlation with fibrinogen. Our study reveals that unfractionated heparin not only prolongs the onset of clot formation but has a significant effect on its fractal microstructure. A progressive increase in unfractionated heparin concentration results in a linear decrease in D(f) and a corresponding prolongation in T(GP). The results represent a new, quantitative measure of clot quality derived from measurements on whole blood samples.
Authors:
Phillip A Evans; Karl Hawkins; Roger H K Morris; Naresh Thirumalai; Roger Munro; Lisa Wakeman; Matthew J Lawrence; P Rhodri Williams
Related Documents :
14605109 - Microbubble potentiated ultrasound as a method of stroke therapy in a pig model: prelim...
981659 - Attenuation measurements of whole blood and blood fractions in computed tomography.
19912209 - Very long half-life plasminogen activator inhibitor type 1 reduces bleeding in a mouse ...
8262749 - Ultrasound-assisted thrombolysis.
15175809 - Encapsulation of a plasminogen activator speeds reperfusion, lessens infarct and reduce...
21523919 - Integration of cardiovascular regulation by the blood/endothelium cell-free layer.
16458209 - Cardiac output measurement during infrarenal aortic surgery: echo-esophageal doppler ve...
14689529 - Uterine artery blood flow velocity waveforms during uterine contractions.
11575109 - Blood flow of free gingival grafts measured by xenon-133 clearance.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-06-21
Journal Detail:
Title:  Blood     Volume:  116     ISSN:  1528-0020     ISO Abbreviation:  Blood     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-29     Completed Date:  2010-12-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3341-6     Citation Subset:  AIM; IM    
Affiliation:
School of Medicine, Swansea University, Swansea, United Kingdom. P.A.Evans@swansea.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Anticoagulants / pharmacology
Blood Coagulation* / drug effects
Blood Coagulation Disorders / diagnosis*
Blood Viscosity / drug effects
Female
Fibrinogen / metabolism
Hemorheology / drug effects
Hemostasis / drug effects
Heparin / pharmacology
Humans
Male
Middle Aged
Thrombelastography* / methods
Young Adult
Chemical
Reg. No./Substance:
0/Anticoagulants; 9001-32-5/Fibrinogen; 9005-49-6/Heparin
Comments/Corrections
Comment In:
Blood. 2010 Oct 28;116(17):3123-4   [PMID:  21030568 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lymphotoxin-alpha contributes to lymphangiogenesis.
Next Document:  Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of ...